Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

PURPOSE: The purpose of the study is to investigate volumetric tumor burden dynamics and tumor growth rates in ALK-rearranged advanced NSCLC patients during crizotinib monotherapy. METHODS: The study included 44 ALK-rearranged advanced NSCLC patients treated with crizotinib monotherapy as their init...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishino, Mizuki, Hida, Tomoyuki, Kravets, Sasha, Dahlberg, Suzanne E., Lydon, Christine A., Hatabu, Hiroto, Johnson, Bruce E., Awad, Mark M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569410/
https://www.ncbi.nlm.nih.gov/pubmed/33102632
http://dx.doi.org/10.1016/j.ejro.2019.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569410/
https://www.ncbi.nlm.nih.gov/pubmed/33102632
http://dx.doi.org/10.1016/j.ejro.2019.12.004

Ejemplares similares